Elevated IL-17 and TGF-β Serum Levels: A Positive Correlation between T-helper 17 Cell-Related Pro-Inflammatory Responses with Major Depressive Disorder

Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforming growth factor β (TGF-β) between patients with major depressive disorder and healthy controls. Blood samples were collected from 41 pati...

Full description

Saved in:
Bibliographic Details
Published inBasic and clinical neuroscience Vol. 7; no. 2; pp. 137 - 142
Main Authors Davami, M., Baharlou, R., Ahmadi Vasmehjani, A., Ghanizadeh, A., Keshtkar, M., Dezhkam, I., Atashzar, M.
Format Journal Article
LanguageEnglish
Published Iran Negah Scientific Publisher 01.04.2016
Iranian Neuroscience Society
Iran University of Medical Sciences
Subjects
Online AccessGet full text
ISSN2228-7442
2008-126X
2228-7442
DOI10.15412/J.BCN.03070207

Cover

Abstract Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforming growth factor β (TGF-β) between patients with major depressive disorder and healthy controls. Blood samples were collected from 41 patients with major depressive disorder and 40 healthy age-matched controls with no history of malignancies or autoimmune disorders. The subjects were interviewed face to face according to DSM-IV diagnostic criteria. Depression score was measured using completed Beck Depression Inventory in both groups. The serum concentrations of IL-21, IL-17, and TGF-β were assessed using ELISA. The mean score of Beck Depression score in the patient and control groups was 35.4±5.5 and 11.1±2.3. IL-17 serum concentrations in the patients and the control group were 10.03±0.6 and 7.6±0.6 pg/mL, respectively (P=0.0002). TGF-β level in the patients group was significantly higher than compare to the control group; 336.7±20.19 vs. 174.8±27.20 pg/mL, (P<0.0001). However, the level of IL-21 was not statistically different between the two groups 84.30±4.57 vs. 84.12±4.15 pg/mL (P>0.05). Considering pro-inflammatory cytokines, current results support the association of inflammatory response and depressive disorder. So, it seems that pro-inflammatory factors profile can be used as indicator in following of depression progress and its treatment impacts.
AbstractList Introduction: Depression is a mental disorder that highly associated with immune system.Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforminggrowth factor β (TGF-β) between patients with major depressive disorder and healthy controls. Methods: Blood samples were collected from 41 patients with major depressive disorder and40 healthy age-matched controls with no history of malignancies or autoimmune disorders. Thesubjects were interviewed face to face according to DSM-IV diagnostic criteria. Depressionscore was measured using completed Beck Depression Inventory in both groups. The serumconcentrations of IL-21, IL-17, and TGF-β were assessed using ELISA. Results: The mean score of Beck Depression score in the patient and control groups was35.4±5.5 and 11.1±2.3. IL-17 serum concentrations in the patients and the control group were10.03±0.6 and 7.6±0.6 pg/mL, respectively (P=0.0002). TGF-β level in the patients group wassignificantly higher than compare to the control group; 336.7±20.19 vs. 174.8±27.20 pg/mL,(P<0.0001). However, the level of IL-21 was not statistically different between the two groups84.30±4.57 vs. 84.12±4.15 pg/mL (P>0.05). Conclusion: Considering pro-inflammatory cytokines, current results support the associationof inflammatory response and depressive disorder. So, it seems that pro-inflammatory factorsprofile can be used as indicator in following of depression progress and its treatment impacts.
Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforming growth factor β (TGF-β) between patients with major depressive disorder and healthy controls. Blood samples were collected from 41 patients with major depressive disorder and 40 healthy age-matched controls with no history of malignancies or autoimmune disorders. The subjects were interviewed face to face according to DSM-IV diagnostic criteria. Depression score was measured using completed Beck Depression Inventory in both groups. The serum concentrations of IL-21, IL-17, and TGF-β were assessed using ELISA. The mean score of Beck Depression score in the patient and control groups was 35.4±5.5 and 11.1±2.3. IL-17 serum concentrations in the patients and the control group were 10.03±0.6 and 7.6±0.6 pg/mL, respectively (P=0.0002). TGF-β level in the patients group was significantly higher than compare to the control group; 336.7±20.19 vs. 174.8±27.20 pg/mL, (P<0.0001). However, the level of IL-21 was not statistically different between the two groups 84.30±4.57 vs. 84.12±4.15 pg/mL (P>0.05). Considering pro-inflammatory cytokines, current results support the association of inflammatory response and depressive disorder. So, it seems that pro-inflammatory factors profile can be used as indicator in following of depression progress and its treatment impacts.
Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforming growth factor β (TGF-β) between patients with major depressive disorder and healthy controls.INTRODUCTIONDepression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforming growth factor β (TGF-β) between patients with major depressive disorder and healthy controls.Blood samples were collected from 41 patients with major depressive disorder and 40 healthy age-matched controls with no history of malignancies or autoimmune disorders. The subjects were interviewed face to face according to DSM-IV diagnostic criteria. Depression score was measured using completed Beck Depression Inventory in both groups. The serum concentrations of IL-21, IL-17, and TGF-β were assessed using ELISA.METHODSBlood samples were collected from 41 patients with major depressive disorder and 40 healthy age-matched controls with no history of malignancies or autoimmune disorders. The subjects were interviewed face to face according to DSM-IV diagnostic criteria. Depression score was measured using completed Beck Depression Inventory in both groups. The serum concentrations of IL-21, IL-17, and TGF-β were assessed using ELISA.The mean score of Beck Depression score in the patient and control groups was 35.4±5.5 and 11.1±2.3. IL-17 serum concentrations in the patients and the control group were 10.03±0.6 and 7.6±0.6 pg/mL, respectively (P=0.0002). TGF-β level in the patients group was significantly higher than compare to the control group; 336.7±20.19 vs. 174.8±27.20 pg/mL, (P<0.0001). However, the level of IL-21 was not statistically different between the two groups 84.30±4.57 vs. 84.12±4.15 pg/mL (P>0.05).RESULTSThe mean score of Beck Depression score in the patient and control groups was 35.4±5.5 and 11.1±2.3. IL-17 serum concentrations in the patients and the control group were 10.03±0.6 and 7.6±0.6 pg/mL, respectively (P=0.0002). TGF-β level in the patients group was significantly higher than compare to the control group; 336.7±20.19 vs. 174.8±27.20 pg/mL, (P<0.0001). However, the level of IL-21 was not statistically different between the two groups 84.30±4.57 vs. 84.12±4.15 pg/mL (P>0.05).Considering pro-inflammatory cytokines, current results support the association of inflammatory response and depressive disorder. So, it seems that pro-inflammatory factors profile can be used as indicator in following of depression progress and its treatment impacts.CONCLUSIONConsidering pro-inflammatory cytokines, current results support the association of inflammatory response and depressive disorder. So, it seems that pro-inflammatory factors profile can be used as indicator in following of depression progress and its treatment impacts.
Introduction: Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforming growth factor β (TGF-β) between patients with major depressive disorder and healthy controls.Methods: Blood samples were collected from 41 patients with major depressive disorder and 40 healthy age-matched controls with no history of malignancies or autoimmune disorders. The subjects were interviewed face to face according to DSM-IV diagnostic criteria. Depression score was measured using completed Beck Depression Inventory in both groups. The serum concentrations of IL-21, IL-17, and TGF-β were assessed using ELISA.Results: The mean score of Beck Depression score in the patient and control groups was 35.4±5.5 and 11.1±2.3. IL-17 serum concentrations in the patients and the control group were 10.03±0.6 and 7.6±0.6 pg/mL, respectively (P=0.0002). TGF-β level in the patients group was significantly higher than compare to the control group; 336.7±20.19 vs. 174.8±27.20 pg/mL, (P<0.0001). However, the level of IL-21 was not statistically different between the two groups 84.30±4.57 vs. 84.12±4.15 pg/mL (P>0.05).Conclusion: Considering pro-inflammatory cytokines, current results support the associationof inflammatory response and depressive disorder. So, it seems that pro-inflammatory factors profile can be used as indicator in following of depression progress and its treatment impacts.
Author Ghanizadeh, A.
Ahmadi Vasmehjani, A.
Dezhkam, I.
Baharlou, R.
Keshtkar, M.
Davami, M.
Atashzar, M.
Author_xml – sequence: 1
  givenname: M.
  surname: Davami
  fullname: Davami, M.
– sequence: 2
  givenname: R.
  surname: Baharlou
  fullname: Baharlou, R.
– sequence: 3
  givenname: A.
  surname: Ahmadi Vasmehjani
  fullname: Ahmadi Vasmehjani, A.
– sequence: 4
  givenname: A.
  surname: Ghanizadeh
  fullname: Ghanizadeh, A.
– sequence: 5
  givenname: M.
  surname: Keshtkar
  fullname: Keshtkar, M.
– sequence: 6
  givenname: I.
  surname: Dezhkam
  fullname: Dezhkam, I.
– sequence: 7
  givenname: M.
  surname: Atashzar
  fullname: Atashzar, M.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27303608$$D View this record in MEDLINE/PubMed
BookMark eNp1kstuEzEUhkeoiJbSNTtkiQ2baX2bsYcFUkkvpApQlbC2PJ4zjSPPONiTVH0UXoMH4ZlwkrZqK-GNLfs7n46P_tfZTu97yLK3BB-SghN6dHH4efTtEDMsMMXiRbZHKZW54JzuPDrvZgcxznFaJWac41fZLhUMsxLLvez3qYOVHqBB40lOBNJ9g6bnZ_nfP-gHhGWHJrACFz-iY3Tpox3sCtDIhwBOD9b3qIbhBqBH03wGbgEBJccInMuv1kTSXgafj_vW6a7Tgw-36AriwvcRIrqxwwx91XMf0AksAsS4tp_Y6EMD4U32stUuwsHdvp_9PDudjr7kk-_n49HxJDdciiEvdNUWZVEShguDixLroqpZTUyaCDbGEEalkYCxlMaIVgLXJVRQ1BQDF9Kw_Wy89TZez9Ui2E6HW-W1VZsLH66VDoM1DhTjgkhWMqN1y2lZ1VVjZAVG6KamZSuT69PWtVjWHTQG-iFo90T69KW3M3XtV4rLijKyFny4EwT_awlxUJ2NJs1T9-CXURFRiYLz9KmEvn-Gzv0y9GlUilQVJoVMHSbq3eOOHlq5T0ACjraACT7GAO0DQrDaxExdqBQzdR-zVFE8qzB22KQhfcm6_9b9A2xi1bs
CitedBy_id crossref_primary_10_3389_fnbeh_2022_1006836
crossref_primary_10_1007_s10608_021_10282_w
crossref_primary_10_1007_s43440_023_00548_3
crossref_primary_10_9758_cpn_2017_15_3_256
crossref_primary_10_3389_fped_2022_893815
crossref_primary_10_3390_jpm11020066
crossref_primary_10_3389_fimmu_2022_1010304
crossref_primary_10_2147_OARRR_S298393
crossref_primary_10_3390_cells12232749
crossref_primary_10_3389_fpsyt_2020_571636
crossref_primary_10_5114_aoms_178276
crossref_primary_10_1002_alr_22287
crossref_primary_10_3390_ijms23020669
crossref_primary_10_3389_fimmu_2021_699848
crossref_primary_10_1007_s00403_017_1765_9
crossref_primary_10_1007_s00406_024_01864_2
crossref_primary_10_3389_fpsyt_2022_936052
crossref_primary_10_1038_s41598_022_22744_6
crossref_primary_10_3389_fimmu_2024_1479471
crossref_primary_10_3389_fphar_2021_649144
crossref_primary_10_23736_S0392_0488_18_06112_6
crossref_primary_10_1080_1744666X_2018_1401468
crossref_primary_10_3389_fpsyt_2023_1130989
crossref_primary_10_2147_ITT_S240891
crossref_primary_10_3389_fimmu_2022_932152
crossref_primary_10_1007_s00221_019_05682_0
crossref_primary_10_1002_iid3_70092
crossref_primary_10_3389_fcimb_2023_1078984
crossref_primary_10_3390_jpm11030220
crossref_primary_10_2478_sjecr_2018_0076
crossref_primary_10_1038_s41380_024_02507_7
crossref_primary_10_1186_s13293_024_00589_0
crossref_primary_10_3389_fpubh_2022_1021309
ContentType Journal Article
Copyright Copyright Negah Scientific Publisher 2016
Copyright© 2016 Iranian Neuroscience Society 2016
Copyright_xml – notice: Copyright Negah Scientific Publisher 2016
– notice: Copyright© 2016 Iranian Neuroscience Society 2016
DBID AAYXX
CITATION
NPM
8FE
8FH
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
HCIFZ
LK8
M7P
PHGZM
PHGZT
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.15412/J.BCN.03070207
DatabaseName CrossRef
PubMed
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
ProQuest Central Student
SciTech Premium Collection
Biological Sciences
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
ProQuest Central Student
ProQuest Biological Science Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Biological Science Database
ProQuest SciTech Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Academic UKI Edition
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
ProQuest Central Student
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2228-7442
EndPage 142
ExternalDocumentID oai_doaj_org_article_34718363caaf4269b9dc89ec7adb26f8
PMC4892318
27303608
10_15412_J_BCN_03070207
Genre Journal Article
GroupedDBID ---
5VS
8FE
8FH
AAYXX
ABDBF
ABIVO
ACPRK
ACUHS
ADBBV
ADRAZ
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
CITATION
DIK
EBD
EOJEC
GROUPED_DOAJ
HCIFZ
HYE
IPNFZ
KQ8
LK8
M48
M7P
OBODZ
OK1
PGMZT
PHGZM
PHGZT
RIG
RPM
M~E
NPM
AZQEC
DWQXO
GNUQQ
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c487t-5a9f56561305c0560a59b3b1c2070ccc1328c8e0088cc7f8e4a6e9e5b20e478c3
IEDL.DBID BENPR
ISSN 2228-7442
2008-126X
IngestDate Wed Aug 27 01:01:07 EDT 2025
Thu Aug 21 14:06:54 EDT 2025
Fri Jul 11 09:12:53 EDT 2025
Fri Jul 25 10:39:14 EDT 2025
Thu Jan 02 22:23:03 EST 2025
Tue Jul 01 03:23:20 EDT 2025
Thu Apr 24 22:59:36 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Inflammatory response
Transforming growth factor-beta
Interleukin-17
interleukin-21
Major depressive disorder
Language English
License This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c487t-5a9f56561305c0560a59b3b1c2070ccc1328c8e0088cc7f8e4a6e9e5b20e478c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/34718363caaf4269b9dc89ec7adb26f8
PMID 27303608
PQID 1990158269
PQPubID 2046373
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_34718363caaf4269b9dc89ec7adb26f8
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4892318
proquest_miscellaneous_1797544132
proquest_journals_1990158269
pubmed_primary_27303608
crossref_primary_10_15412_J_BCN_03070207
crossref_citationtrail_10_15412_J_BCN_03070207
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-04-01
PublicationDateYYYYMMDD 2016-04-01
PublicationDate_xml – month: 04
  year: 2016
  text: 2016-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Iran
PublicationPlace_xml – name: Iran
– name: Tehran
PublicationTitle Basic and clinical neuroscience
PublicationTitleAlternate Basic Clin Neurosci
PublicationYear 2016
Publisher Negah Scientific Publisher
Iranian Neuroscience Society
Iran University of Medical Sciences
Publisher_xml – name: Negah Scientific Publisher
– name: Iranian Neuroscience Society
– name: Iran University of Medical Sciences
References 20083665 - J Immunol. 2010 Feb 15;184(4):1776-83
19262136 - Cell Adh Migr. 2007 Jul-Sep;1(3):142-4
20373471 - Hum Psychopharmacol. 2010 Apr;25(3):201-15
24302954 - Psychiatry Investig. 2013 Sep;10(3):294-9
23174342 - Biol Psychiatry. 2013 Apr 1;73(7):622-30
20383173 - Cell Mol Immunol. 2010 May;7(3):164-74
18483277 - Cancer Res. 2008 May 15;68(10):3915-23
21391901 - Expert Opin Ther Targets. 2011 Jun;15(6):695-702
20452036 - Psychiatry Res. 2010 Jun 30;178(1):92-6
18317531 - Clin Dev Immunol. 2007;2007:76396
21585245 - Ann Med. 2011 Nov;43(7):503-11
17433516 - Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1044-53
12461566 - Nat Rev Immunol. 2002 Dec;2(12):933-44
21684012 - J Affect Disord. 2011 Nov;134(1-3):217-25
21787348 - Biochem Soc Trans. 2011 Aug;39(4):1061-6
14631599 - Psychiatr Pol. 2003 Sep-Oct;37(5):787-98
9472719 - Life Sci. 1998;62(7):583-606
9770242 - Prog Neurobiol. 1998 Oct;56(3):307-40
17360153 - Brain Behav Immun. 2007 May;21(4):374-83
23172104 - Neuroimmunomodulation. 2013;20(1):39-50
17569825 - Science. 2007 Jul 13;317(5835):256-60
24257035 - Toxins (Basel). 2013 Nov 19;5(11):2227-40
16782542 - Int Immunopharmacol. 2006 Aug;6(8):1298-304
16200070 - Nat Immunol. 2005 Nov;6(11):1123-32
15694227 - Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):201-17
23527713 - Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1):107-15
22533549 - Inflamm Allergy Drug Targets. 2012 Aug 1;11(4):313-9
17919797 - Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):356-61
References_xml – reference: 9472719 - Life Sci. 1998;62(7):583-606
– reference: 18317531 - Clin Dev Immunol. 2007;2007:76396
– reference: 20083665 - J Immunol. 2010 Feb 15;184(4):1776-83
– reference: 23172104 - Neuroimmunomodulation. 2013;20(1):39-50
– reference: 21787348 - Biochem Soc Trans. 2011 Aug;39(4):1061-6
– reference: 20383173 - Cell Mol Immunol. 2010 May;7(3):164-74
– reference: 21684012 - J Affect Disord. 2011 Nov;134(1-3):217-25
– reference: 17360153 - Brain Behav Immun. 2007 May;21(4):374-83
– reference: 9770242 - Prog Neurobiol. 1998 Oct;56(3):307-40
– reference: 12461566 - Nat Rev Immunol. 2002 Dec;2(12):933-44
– reference: 15694227 - Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):201-17
– reference: 16200070 - Nat Immunol. 2005 Nov;6(11):1123-32
– reference: 19262136 - Cell Adh Migr. 2007 Jul-Sep;1(3):142-4
– reference: 16782542 - Int Immunopharmacol. 2006 Aug;6(8):1298-304
– reference: 17919797 - Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):356-61
– reference: 20452036 - Psychiatry Res. 2010 Jun 30;178(1):92-6
– reference: 24302954 - Psychiatry Investig. 2013 Sep;10(3):294-9
– reference: 23174342 - Biol Psychiatry. 2013 Apr 1;73(7):622-30
– reference: 14631599 - Psychiatr Pol. 2003 Sep-Oct;37(5):787-98
– reference: 17569825 - Science. 2007 Jul 13;317(5835):256-60
– reference: 22533549 - Inflamm Allergy Drug Targets. 2012 Aug 1;11(4):313-9
– reference: 21391901 - Expert Opin Ther Targets. 2011 Jun;15(6):695-702
– reference: 18483277 - Cancer Res. 2008 May 15;68(10):3915-23
– reference: 20373471 - Hum Psychopharmacol. 2010 Apr;25(3):201-15
– reference: 17433516 - Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1044-53
– reference: 24257035 - Toxins (Basel). 2013 Nov 19;5(11):2227-40
– reference: 21585245 - Ann Med. 2011 Nov;43(7):503-11
– reference: 23527713 - Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1):107-15
SSID ssj0000603440
ssib044731253
Score 2.3632398
Snippet Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and...
Introduction: Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21,...
Introduction: Depression is a mental disorder that highly associated with immune system.Therefore, this study compares the serum concentrations of IL-21,...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 137
SubjectTerms Autoimmune diseases
Enzyme-linked immunosorbent assay
Immune system
Inflammatory response
Interleukin 17
Interleukin 21
Major depressive disorder
Mental depression
Research Papers
Serum levels
Transforming growth factor-b
Transforming growth factor-beta
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQD4gLovwGCjISBy7eJnF-bG7t0qVddasKbaW9RfbEUUFpttqfvktfgwfhmZhxstEuAnHhmjhWMjP2fOP5MsPYB_QZMoosiExXlSDIIIzMjQAHcVlp3DQNBYqTi-z0KhnP0tlWqy_ihLXlgVvBHUraPWUmwZiKfru0ugSlHeSmtHFW-d98Qx1uBVNoSUmSS_Tcsj9tCTMqbUcHLj7fH8XZrKvzkyZRfDgeHA8vBt7-Y2osu-WifCX_P8HP31mUW25p9IQ97vAkP2q_Y589cM1T9nDSZcyfsfuT2t0hniz52bmIcm6akk-_jMTPHxy3ifUNPyfW0PITP-KXnr915_iQOna0HDne8bj4VFy7-tYtOM4xdHUtPIsOp71czMVZU6Fh3fiEPf_asm7dktMZL5-Y7_MF_9wRbnH2Tb3P5-xqdDIdnoquHYMAjGpWIjW6IviHXi8FxE2hSbWVNgIUWQgAGNcqUA7lqwDySrnEZE671MahS3IF8gXba-aNe8V4aWUMOpdGJxHK3yppVaogjpVB-KmrgA02Giigq1VOLTPqgmIWUlkxLlBlxUZlAfvYP3Dblun4-9BjUmk_jOpr-wtodUVndcW_rC5gBxuDKLpFvywiyjGmGK_pgL3vb-NypRyMadx8jWNyTSUHUVYBe9naT_8miCQRT4Q4eb5jWTuvunun-XbtS4InioC6ev0_vu0Ne4SoMGvpSQdsb7VYu7eIvFb2nV9kvwAApCeW
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1tb9MwELbQkBBfEO8EBjISH_ji0sR5sZEQ2srKVq3ThFqp3yLbcTZQloy0neCn8Df4Ifwm7pyXUVT42rgn6-6ce8735I6QVxAzuO9rw2KZ5wwhA1M8UcxYE2S5hJemwkRxehIfzsPJIlpcjwNqFbjcmtrhPKl5XQy-ff3-Hg78Oze9J_SDN5PB_uhk4Nw3wC_Lb7piEfL4rrF-GCYcgjnvL2CGMXa7wzsYRwHwg3jRtv7ZInMjarnm_tsQ6d_Eyj8i1fguudNCTLrX-MQ9csOW98mtaVtEf0B-HBT2CiBmRo-OmZ9QVWZ09nHMfv2k8OZYX9BjJBIt39I9euooXVeWjnCIR0Oboy21i87YuS0ubU1BxsgWBXPEOhB7WlfsqMzB1y5cDZ9-aoi4dknx2pdO1Zeqph9aDi5I71qAPiTz8cFsdMjaCQ3MQKKzYpGSOSJC0HZkAEoNVSQ1174BlQ2NMZDqCiMs6FcYk-TChiq20kY6GNowEYY_IjtlVdonhGaaB0YmXMnQB_1rwbWIhAkCoQCRytwjg84CqWnbl-MUjSLFNAZNlk5SMFnamcwjr_s_XDadO_69dB9N2i_Dltvuh6o-S9sTnHIM4zzmRqkcv__VMjNCWpOoTAdxLjyy2zlE2rlx6mPZMYIUTnrkZf8YTjCWZVRpqzWsSSR2IQRdeeRx4z_9TgBcAsQYgvBkw7M2trr5pPx87rqEhwKxu3j6_209I7cBAsYNF2mX7KzqtX0OMGulX7jj8xvy9iEb
  priority: 102
  providerName: Scholars Portal
Title Elevated IL-17 and TGF-β Serum Levels: A Positive Correlation between T-helper 17 Cell-Related Pro-Inflammatory Responses with Major Depressive Disorder
URI https://www.ncbi.nlm.nih.gov/pubmed/27303608
https://www.proquest.com/docview/1990158269
https://www.proquest.com/docview/1797544132
https://pubmed.ncbi.nlm.nih.gov/PMC4892318
https://doaj.org/article/34718363caaf4269b9dc89ec7adb26f8
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NjtMwELaWVkJcVvzTZamMxIGLu0mcHxsJobbbslttq2rVlXqLHMdhQd2k9GePvAevwYPwTMw4Sdki4JJD4liWZzzzefx5hpA34DO46yaahTLLGEIGpnikmDbaSzMJRlPhRnE8Cc-u_NE8mB-QSX0XBmmVtU20hjotNMbIT1w8wAkADMsPy68Mq0bh6WpdQkNVpRXS9zbF2D3SBJMcOA3S7A0m08taw3w_4vCe76IwTogp7zAQY3kArhfOq_w_ge96J6NOrz_p2HXhYcHZO67LZvj_Gyz9k115x10NH5LDCmfSbqkYj8iByR-T--PqJP0J-T5YmFvAmSk9v2BuRFWe0tnHIfv5g4L52N7QC2QTrd_RLp1aXtetoX2s5FFy52jF76Izdm0WS7Oi0EffLBbMsuug2-mqYOd5Bgp3Yw_y6WXJxjVrirFfOlZfihU9rYi40HudB_QpuRoOZv0zVpVpYBp2OxsWKJkhLARvGGjAU44KZMITV8OUOVpr2O8KLQzMr9A6yoTxVWikCRLPMX4kNH9GGnmRmxeEpgn3tIy4kr4L858InohAaM8TCmCpzFqkU0sg1lUOcyylsYhxL4Mii0cxiCyuRdYib3c_LMv0Hf9u2kOR7pph3m37olh9iqtlHHP05TzkWqkMLwEnMtVCGh2pNPHCTLTIca0QcWUM1vFv1W2R17vPsIzxbEblpthCm0hiKkKYqxZ5XurPbiSAMAFnONB5tKdZe0Pd_5J_vrapwn2BAF4c_X9YL8kDwIFhSUg6Jo3NamteAdbaJG3S7PZOe8N2tZDaNmYBz7Ev8Plt8AubIimN
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dbtMwFLZGJwE3iH8KA4wEEjfumjg_NtKE1q6l7dqqmjqpd8FxHAbqktKfIR6F1-ABeASeiXNSp6wIuNtt4hxZOT_-jv35HEJewprBHSfWLJBpyhAyMMVDxbTRbpJKCJoKE8XBMOicer2JP9khP8q7MEirLGNiEaiTXOMe-b6DBzg-gGH5dvaZYdcoPF0tW2go21ohOShKjNmLHcfm6xdI4RYH3SPQ9yvXbbfGzQ6zXQaYBrC-ZL6SKaIaCOa-BjhQV76MeexoF7xBaw3pmtDCwFoptA5TYTwVGGn82K0bLxSag9xrZNfDDZQK2W20hqOT0qI9L-SAIPhm16ceYIk93PgpeAeOG0xsvSHfc9z9Xq3RHNYKP3Sxwe2lpbLoKPA3GPwnm_PS8ti-TW5ZXEsP14Z4h-yY7C65PrAn9_fIt9bUXACuTWi3z5yQqiyh43dt9vM7hXC1Oqd9ZC8t3tBDOip4ZBeGNrFzyJqrRy2fjI7ZmZnOzJyCjKaZTlnB5gOxo3nOulkKBn5eEAfoyZr9axYU95rpQH3K5_TIEn9Bell39D45vRKFPSCVLM_MI0KTmLtahlxJz4H_HwseC19o1xUKYLBMq6RWaiDStmY6tu6YRpg7ocqiXgQqi0qVVcnrzQezdbmQfw9toEo3w7DOd_Egn3-IbNiIOGIHHnCtVIqXjmOZaCGNDlUSu0EqqmSvNIjIBp9F9NtVquTF5jWEDTwLUpnJVzAmlFj6EP5VlTxc289mJoBoAdfUQXi4ZVlbU91-k308K0qTewITBvH4_9N6Tm50xoN-1O8Oj5-Qm4BBgzUZao9UlvOVeQo4bxk_s85Eyfur9t9fVHxhCg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevated+IL-17+and+TGF-%CE%B2+Serum+Levels%3A+A+Positive+Correlation+between+T-helper+17+Cell-Related+Pro-Inflammatory+Responses+with+Major+Depressive+Disorder&rft.jtitle=Basic+and+clinical+neuroscience&rft.au=Davami%2C+Mohammad+Hasan&rft.au=Baharlou%2C+Rasoul&rft.au=Abbas+Ahmadi+Vasmehjani&rft.au=Ghanizadeh%2C+Ahmad&rft.date=2016-04-01&rft.pub=Negah+Scientific+Publisher&rft.issn=2008-126X&rft.eissn=2228-7442&rft.volume=7&rft.issue=2&rft.spage=137&rft_id=info:doi/10.15412%2FJ.BCN.03070207
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2228-7442&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2228-7442&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2228-7442&client=summon